Recordati Industria Chimica e Farmaceutica

Board/Management Information • Oct 11, 2021

RECORDATI: RESIGNATION OF A NON-EXECUTIVE DIRECTOR

Milan, 11th October 2021 – The Company communicates the receipt today of Mr. Francesco Balestrieri's resignation as member of the Board of Directors of the Company, effective as of 15th October, due to a new professional appointment and the consequent incompatibility of the latter with his office as director of the Company.

Mr. Balestrieri is a non-executive Director and, as of today, on the basis of the information available to Recordati S.p.A., does not hold any Company's shares.

The Chairman and the Chief Executive Officer, on behalf of the entire Board of Directors, thank Mr. Balestrieri for his contribution to the Board's work during his term of office and wish him all the best for his new professional appointment.

Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of more than 4,300, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in Europe, Russia and the other C.I.S. countries, Ukraine, Turkey, North Africa, the United States of America, Canada, Mexico, some South American countries, Japan and Australia. An efficient field force of medical representatives promotes a wide range of innovative pharmaceuticals, both proprietary and under license, in several therapeutic areas including a specialized business dedicated to treatments for rare diseases. Recordati is a partner of choice for new product licenses for its territories. Recordati is committed to the research and development of new specialties with a focus on treatments for rare diseases. Consolidated revenue for 2020 was € 1,448.9 million, operating income was € 469.0 million and net income was € 355.0 million.

For further information:

Recordati website: www.recordati.com

Investor Relations Media Relations (39) 02 48787146 (39) 02 9288 6200

Federica De Medici Brunswick - Barbara Scalchi / Andrea Mormandi e-mail: investorelations@recordati.it e-mail: recordati@brunswickgroup.com

RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.A.

Registered Office Via Matteo Civitali, 1 20148 Milano, Italy Ph. (39) 02 487871 Fax (39) 02 40073747 www.recordati.com

Share Capital € 26.140.644,50 fully paid-up Milano, Monza, Brianza and Lodi Comp. Reg. No. 00748210150 Tax Code/VAT No. 00748210150 Milano R.E.A. No. 401832

Company subject to the Management and Coordination Activity of Rossini Luxembourg S.àr.l